HCC - Subtypes, stratification and sorafenib

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

Original languageEnglish (US)
Pages (from-to)645-647
Number of pages3
JournalNature Reviews Gastroenterology and Hepatology
Volume11
Issue number11
DOIs
StatePublished - Nov 5 2014

Fingerprint

Hepatocellular Carcinoma
Neoplasms
sorafenib

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

HCC - Subtypes, stratification and sorafenib. / Gores, Gregory James.

In: Nature Reviews Gastroenterology and Hepatology, Vol. 11, No. 11, 05.11.2014, p. 645-647.

Research output: Contribution to journalArticle

@article{7218ea62bf474490a6164c4178c221ad,
title = "HCC - Subtypes, stratification and sorafenib",
abstract = "The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.",
author = "Gores, {Gregory James}",
year = "2014",
month = "11",
day = "5",
doi = "10.1038/nrgastro.2014.157",
language = "English (US)",
volume = "11",
pages = "645--647",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - HCC - Subtypes, stratification and sorafenib

AU - Gores, Gregory James

PY - 2014/11/5

Y1 - 2014/11/5

N2 - The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

AB - The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

UR - http://www.scopus.com/inward/record.url?scp=84908551424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908551424&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2014.157

DO - 10.1038/nrgastro.2014.157

M3 - Article

C2 - 25245016

AN - SCOPUS:84908551424

VL - 11

SP - 645

EP - 647

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 11

ER -